As the climate crisis alters familiar growing conditions, we urgently need to find ways of protecting the world against famines.
Elamipretide for Barth Syndrome Survives FDA Advisory Vote
FDA advisors indicated a possible path forward for elamipretide as a treatment for Barth syndrome despite the lack of definitive evidence. On Thursday, the Cardiovascular
October 12, 2024